345 related articles for article (PubMed ID: 26100636)
21. P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease.
Fan J; Gladding CM; Wang L; Zhang LY; Kaufman AM; Milnerwood AJ; Raymond LA
Neurobiol Dis; 2012 Mar; 45(3):999-1009. PubMed ID: 22198502
[TBL] [Abstract][Full Text] [Related]
22. p53 regulates apoptotic retinal ganglion cell death induced by N-methyl-D-aspartate.
Li Y; Schlamp CL; Poulsen GL; Jackson MW; Griep AE; Nickells RW
Mol Vis; 2002 Sep; 8():341-50. PubMed ID: 12355059
[TBL] [Abstract][Full Text] [Related]
23. A microscopy-based small molecule screen in primary neurons reveals neuroprotective properties of the FDA-approved anti-viral drug Elvitegravir.
Merz SF; Bengtson CP; Tepohl C; Hagenston AM; Bading H; Bas-Orth C
Mol Brain; 2020 Sep; 13(1):124. PubMed ID: 32928261
[TBL] [Abstract][Full Text] [Related]
24. Glutamate-induced excitotoxicity in retina: neuroprotection with receptor antagonist, dextromethorphan, but not with calcium channel blockers.
Calzada JI; Jones BE; Netland PA; Johnson DA
Neurochem Res; 2002 Feb; 27(1-2):79-88. PubMed ID: 11926279
[TBL] [Abstract][Full Text] [Related]
25. Damaging effects of BMAA on retina neurons and Müller glial cells.
Soto T; Buzzi ED; Rotstein NP; German OL; Politi LE
Exp Eye Res; 2021 Jan; 202():108342. PubMed ID: 33144094
[TBL] [Abstract][Full Text] [Related]
26. Effect of nafamostat on N-methyl-D-aspartate-induced retinal neuronal and capillary degeneration in rats.
Tsuda Y; Nakahara T; Ueda K; Mori A; Sakamoto K; Ishii K
Biol Pharm Bull; 2012; 35(12):2209-13. PubMed ID: 23207773
[TBL] [Abstract][Full Text] [Related]
27. Tetramethylpyrazine nitrone protects retinal ganglion cells against N-methyl-d-aspartate-induced excitotoxicity.
Luo X; Yu Y; Xiang Z; Wu H; Ramakrishna S; Wang Y; So KF; Zhang Z; Xu Y
J Neurochem; 2017 May; 141(3):373-386. PubMed ID: 28160291
[TBL] [Abstract][Full Text] [Related]
28. Quantification of amino acid neurochemistry secondary to NMDA or betaxolol application.
Sun D; Kalloniatis M
Clin Exp Ophthalmol; 2004 Oct; 32(5):505-17. PubMed ID: 15498063
[TBL] [Abstract][Full Text] [Related]
29. Caspase-independent component of retinal ganglion cell death, in vitro.
Tezel G; Yang X
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4049-59. PubMed ID: 15505055
[TBL] [Abstract][Full Text] [Related]
30. Liraglutide alleviates H
Ma X; Lin W; Lin Z; Hao M; Gao X; Zhang Y; Kuang H
Peptides; 2017 Jun; 92():1-8. PubMed ID: 28450048
[TBL] [Abstract][Full Text] [Related]
31. Activation of NMDA receptors protects against glutamate neurotoxicity in the retina: evidence for the involvement of neurotrophins.
Rocha M; Martins RA; Linden R
Brain Res; 1999 May; 827(1-2):79-92. PubMed ID: 10320696
[TBL] [Abstract][Full Text] [Related]
32. Small-molecule inhibitors at the PSD-95/nNOS interface protect against glutamate-induced neuronal atrophy in primary cortical neurons.
Doucet MV; O'Toole E; Connor T; Harkin A
Neuroscience; 2015 Aug; 301():421-38. PubMed ID: 26071957
[TBL] [Abstract][Full Text] [Related]
33. Role of caspases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons.
Tenneti L; D'Emilia DM; Troy CM; Lipton SA
J Neurochem; 1998 Sep; 71(3):946-59. PubMed ID: 9721720
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial inhibition in rat retinal cell cultures as a model of metabolic compromise: mechanisms of injury and neuroprotection.
Wood JP; Mammone T; Chidlow G; Greenwell T; Casson RJ
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4897-909. PubMed ID: 22736607
[TBL] [Abstract][Full Text] [Related]
35. Small-molecule inhibitors at the PSD-95/nNOS interface attenuate MPP+-induced neuronal injury through Sirt3 mediated inhibition of mitochondrial dysfunction.
Hu W; Guan LS; Dang XB; Ren PY; Zhang YL
Neurochem Int; 2014 Dec; 79():57-64. PubMed ID: 25452082
[TBL] [Abstract][Full Text] [Related]
36. PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors.
Cui H; Hayashi A; Sun HS; Belmares MP; Cobey C; Phan T; Schweizer J; Salter MW; Wang YT; Tasker RA; Garman D; Rabinowitz J; Lu PS; Tymianski M
J Neurosci; 2007 Sep; 27(37):9901-15. PubMed ID: 17855605
[TBL] [Abstract][Full Text] [Related]
37. Evidence that brain-derived neurotrophic factor neuroprotection is linked to its ability to reverse the NMDA-induced inactivation of protein kinase C in cortical neurons.
Tremblay R; Hewitt K; Lesiuk H; Mealing G; Morley P; Durkin JP
J Neurochem; 1999 Jan; 72(1):102-11. PubMed ID: 9886060
[TBL] [Abstract][Full Text] [Related]
38. Curcumin protects against NMDA-induced toxicity: a possible role for NR2A subunit.
Matteucci A; Cammarota R; Paradisi S; Varano M; Balduzzi M; Leo L; Bellenchi GC; De Nuccio C; Carnovale-Scalzo G; Scorcia G; Frank C; Mallozzi C; Di Stasi AM; Visentin S; Malchiodi-Albedi F
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):1070-7. PubMed ID: 20861489
[TBL] [Abstract][Full Text] [Related]
39. Apelin-36 is protective against N-methyl-D-aspartic-acid-induced retinal ganglion cell death in the mice.
Sakamoto K; Murakami Y; Sawada S; Ushikubo H; Mori A; Nakahara T; Ishii K
Eur J Pharmacol; 2016 Nov; 791():213-220. PubMed ID: 27590359
[TBL] [Abstract][Full Text] [Related]
40. Neuroprotective role of superoxide dismutase 1 in retinal ganglion cells and inner nuclear layer cells against N-methyl-d-aspartate-induced cytotoxicity.
Yuki K; Yoshida T; Miyake S; Tsubota K; Ozawa Y
Exp Eye Res; 2013 Oct; 115():230-8. PubMed ID: 23856406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
